Delivery Order SPE2DB22D2103-SPE2DB25FR9HG
- Not listed
- The Defense Logistics Agency awarded a $42,494.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $14,697.32 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets (10-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $44,091.96 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency has awarded a delivery order valued at $22,045.98 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets in quantities of 10 tablets per unit. This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,247.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Samsca 15 mg tablets (10-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by September 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.60 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- This is a $21,304.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of SAMSCA 30 MG TABLET 10S, a specialty medication. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) that runs through November 2024. This delivery order is part of a larger $999,999,999 IDC held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $20,539.62 contract is for the delivery of SAMSCA 15 MG TABLET 10S to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 16, 2024 and was awarded on January 26, 2024. This delivery order is issued under a larger, single-award indefinite delivery...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9HGDelivery Order
The Defense Logistics Agency awarded a $11,022.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This non-set-aside contract is scheduled for completion by June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement and holds an extensive Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain. The contract supports military and veteran healthcare systems' pharmaceutical needs through competitively awarded, fixed-price transactions. SAMSCA (tolvaptan) is a vasopressin antagonist used in clinical settings, reflecting the range of specialty medications AmerisourceBergen supplies to federal healthcare programs. The company's federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support Department of Defense and other federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 5/27/25 |